News: breast cancer
DRMCRL researchers attend the 32nd IABCR Conference in Mexico
DRMCRL researchers are attending and presenting at the 32nd International Association for Breast Cancer Research Conference (IABCR 2023) in Tulum, Mexico.
[Read more about DRMCRL researchers attend the 32nd IABCR Conference in Mexico]
International PacRim Breast and Prostate Cancer Meeting – 2024
In 2024, we will be celebrating the 21st anniversary of the International Pacific Rim (PacRim) Breast and Prostate Cancer Meeting series, twenty-one years after the inaugural PacRim Meeting was held in southern Australia.
[Read more about International PacRim Breast and Prostate Cancer Meeting – 2024]
2022 Florey Postgraduate Research Conference prize recipient
The Florey Postgraduate Research Conference, held on 21 September at the Adelaide Convention Centre, was a highlight for the Faculty of Health and Medical Sciences Faculty showcasing outstanding research activity. DRMCRL PhD student Wenjun (Nora) Liu was awarded the Florey Medical Research Foundation (Applied) prize for achieving the highest score in the applied science field for her poster presentation “Make sense of noisy patient-derived data: A novel workflow for deconvoluting bulk RNA-seq data to unveil transcriptional responses to androgen in breast tissues". Well done Nora! The conference, now in its 16th year, gives HDR students the opportunity to discuss their research with fellow students, academics, industry partners, and other major stakeholders of the University. It is a chance to recognise excellent in research, hear from distinguished speakers on specialised topics, and beneficial to HDR students for ongoing professional and personal development. 2022 Florey Postgraduate Conference prize list here. See Nora on Twitter here.
[Read more about 2022 Florey Postgraduate Research Conference prize recipient]
Cancer Australia funding for arming androgen receptors to transform endocrine therapy for ER+ breast cancer
Associate Professor Theresa Hickey and her team have received $600,000 from Cancer Australia to support research to examine the complex interaction between estrogen and androgen to develop new, more effective strategies for treating breast cancer, with potential to also improve quality of life.
Latest news in breast cancer trials meeting
Breast Cancer Trials (BCT) held their 43rd Annual Scientific Meeting in Melbourne on July 27-30.
In the Translational Research session at this meeting, Prof Wayne Tilley, Director of the Dame Roma Mitchell Cancer Research Laboratories (DRMCRL) presented work on "Understanding the role of the androgen receptor" as targeting the androgen receptor (AR) in breast cancer has been of intense clinical interest over the past two decades.
[Read more about Latest news in breast cancer trials meeting]
DRMCRL Team – MDC winners four consecutive years running!
DRMCRL lab members participated in the NBCF 2022 Mothers Day Classic (MDC) with a 5km River Torrens circuit, and for the fourth straight year have won the trophy for the Largest Higher Education Team in South Australia.
[Read more about DRMCRL Team – MDC winners four consecutive years running!]
DRMCRL research presented at the 3rd Nuclear Receptors Conference, 4 -7 May 2022
DRMCRL Director, Prof Wayne Tilley and Prof Charlotte Bevan (Imperial College London) co-chaired the 3rd Nuclear Receptor meeting, which returned to a face to face format in Cancun, Mexico, after being postponed for the last two years.
[Read more about DRMCRL research presented at the 3rd Nuclear Receptors Conference, 4 -7 May 2022]
Associate Professor Alex Swarbrick presented at the Adelaide Medical School Distinguished Speaker Series 2022
Associate Professor Alex Swarbrick, Senior Principal Research Fellow and co-leader of the Strategic program in Dynamic Cancer Ecosystems, Garvan Institute of Medical Research, Sydney presented a seminar entitled "Solid tumours as cellular ecosystems: new insights into disease stratification and treatment", on 7 April, 2022, in the AHMS Building, University of Adelaide. The seminar covered how new technologies, including single cell sequencing and high-dimensionality tissue analysis, are enabling new insights into cancer ecosystems, leading to advances in the stratification and treatment of solid cancers. A/Prof Swarbrick is a developmental biologist with a long-standing interest in how cells in developing embryos control the decision to divide or to differentiate in co-ordination with cell cycle events, as well as how this co-ordination is subverted in cancers. The seminar was hosted by Prof Wayne Tilley, DRMCRL Director.
DRMCRL researchers attend 34th Annual Lorne Cancer Conference 2022
Professor Wayne Tilley, Associate Professor Theresa Hickey and Dr Amy Dwyer attended the 2022 Annual Lorne Cancer Conference (https://www.lornecancer.org/) held at the Mantra Lorne. Assoc Prof Hickey gave a first session talk on "The androgen receptor as a therapeutic target in breast cancer", and Amy gave a Flash Talk on "High throughput cell morphology-based drug-screens in breast and prostate cancer reveals novel AR agonists". Both presentations were very well received.
[Read more about DRMCRL researchers attend 34th Annual Lorne Cancer Conference 2022]
Well done Ebtihal Mustafa - PhD awarded!
Congratulations to Ebtihal Mustafa for great work in completing her doctoral thesis on "Development of a novel therapeutic strategy for estrogen receptor negative breast cancer". And in further good news, Ebi will start a postdoctoral position in October with Assoc Prof Nicholas Clemons at the Peter MacCallum Cancer Centre, Melbourne whose research interests are in fundamental cancer biology and pre-clinical development of innovative therapeutic strategies and translational research, with a focus on upper gastrointestinal cancers. Best of luck Ebi!
